Consumption of stearidonic acid-rich oil in foods increases red blood cell eicosapentaenoic acid

Journal of the Academy of Nutrition and Dietetics

Volumn 113, Issue 8, 2013, Pages 1044-1056

  Lemke, Shawna L ^a   Maki, Kevin C ^b   Hughes, Glenna ^c   Taylor, Mary L ^a   Krul, Elaine S ^c   Goldstein, Daniel A ^a   Su, Hong ^a,d   Rains, Tia M ^b   Mukherjea, Ratna ^c  

^a MONSANTO COMPANY   (United States)

^b Biofortis Clinical Research   (United States)

^c Solae LLC   (United States)

^d NONE

Author keywords

Eicosapentaenoic acid; Omega 3 Index; Red blood cells; Stearidonic acid

Indexed keywords

ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; SOYBEAN OIL; STEARIDONIC ACID;

ADULT; AGED; ARTICLE; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; OMEGA-3 INDEX; RANDOMIZED CONTROLLED TRIAL; RED BLOOD CELLS; SEA FOOD; STANDARD;

EICOSAPENTAENOIC ACID; OMEGA-3 INDEX; RED BLOOD CELLS; STEARIDONIC ACID;

ADULT; AGED; DIET; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HEALTH STATUS; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; NUTRITION POLICY; SEAFOOD; SOYBEAN OIL; YOUNG ADULT;

EID: 84880661666     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2013.04.020     Document Type: Article

References (58)

1. Albert C.M., Hennekens C.H., O'Donnell C.J., et al. Fish consumption and risk of sudden cardiac death. JAMA 1998, 279(1):23-28.
2. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999, 354(9177):447-455. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
3. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
4. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., Tracy R.P., Siscovick D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: The Cardiovascular Health Study. Am J Clin Nutr 2003, 77(2):319-325.
5. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am J Clin Nutr 2006, 84(1):5-17.
6. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090-1098.
7. Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. JAm Coll Cardiol 2009, 54(7):585-594.
8. Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114(1):82-96.
9. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. JNutr 2009, 139(4):804S-819S.
10. Gebauer S.K., Psota T.L., Harris W.S., Kris-Etherton P.M. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006, 83(6 Suppl):1526S-1535S.
11. Mahaffey K.R., Sunderland E.M., Chan H.M., et al. Balancing the benefits of n-3 polyunsaturated fatty acids and the risks of methylmercury exposure from fish consumption. Nutr Rev 2011, 69(9):493-508.
12. Worm B., Barbier E.B., Beaumont N., et al. Impacts of biodiversity loss on ocean ecosystem services. Science 2006, 314(5800):787-790.
13. Jenkins D.J., Sievenpiper J.L., Pauly D., Sumaila U.R., Kendall C.W., Mowat F.M. Are dietary recommendations for the use of fish oils sustainable?. CMAJ 2009, 180(6):633-637.
14. Taneja A., Singh H. Challenges for the delivery of long-chain n-3 fattyacids in functional foods. Annu Rev Food Sci Technol 2012, 3:105-123.
15. Brenna J.T. Efficiency of conversion of a-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002, 5(2):127-132.
16. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80(2-3):85-91.
17. Burdge G., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005, 45(5):581-597.
18. James M.J., Ursin V.M., Cleland L.G. Metabolism of stearidonic acid in human subjects: Comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 2003, 77(5):1140-1145.
19. Plourde M., Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007, 32(4):619-634.
20. Yamazaki K., Fujikawa M., Hamazaki T., Yano S., Shono T. Comparison of the conversion rates of alpha-linolenic acid (18:3(n-3)) and stearidonic acid (18:4(n-3)) to longer polyunsaturated fatty acids in rats. Biochim Biophys Acta 1992, 1123(1):18-26.
21. Harris W.S. Alpha-linolenic acid: A gift from the land?. Circulation 2005, 111(22):2872-2874.
22. Pan A., Chen M., Chowdhury R., et al. Alpha-linolenic acid and risk of cardiovascular disease: A systematic review and meta-analysis. Am J Clin Nutr 2012, 96(6):1262-1273.
23. Ursin V.M. Modification of plant lipids for human health: Development of functional land-based omega-3 fatty acids. JNutr 2003, 133(12):4271-4274.
24. Clemente T.E., Cahoon E.B. Soybean oil: Genetic approaches for modification of functionality and total content. Plant Physiol 2009, 151(3):1030-1040.
25. Harris W.S. Stearidonic acid-enhanced soybean oil: A plant-based source of (n-3) fatty acids for foods. JNutr 2012, 142(3):600S-604S.
26. Harris W.S., Lemke S.L., Hansen S.N., et al. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43(9):805-811.
27. Krul E.S., Lemke S.L., Mukherjea R., et al. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot Essent Fatty Acids 2012, 86(1-2):51-59.
28. Lemke S.L., Vicini J.L., Su H., et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: Randomized, double-blind clinical study of efficacy and safety. Am J Clin Nutr 2010, 92(4):766-775.
29. Decker E.A., Akoh C.C., Wilkes R.S. Incorporation of (n-3) fatty acids infoods: Challenges and opportunities. JNutr 2012, 142(3):610S-613S.
30. Whittinghill J., Welsby D. Use of SDA soybean oil in bakery applications. Lipid Technol 2010, 22(9):203-205.
31. Harris W.S., Von Schacky C. The Omega-3 Index: A new risk factor fordeath from coronary heart disease?. Prev Med 2004, 39(1):212-220.
32. Harris W.S. The omega-3 index: From biomarker to risk marker to risk factor. Curr Atheroscler Rep 2009, 11(6):411-417.
33. Harris W.S. Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor. Pharmacol Res 2007, 55(3):217-223.
34. Harris W.S., Kris-Etherton P.M., Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008, 10(6):503-509.
35. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: Correlation with erythrocytes and response to supplementation. Circulation 2004, 110(12):1645-1649.
36. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274(17):1363-1367.
37. Gregory M.K., Gibson R.A., Cook-Johnson R.J., Cleland L.G., James M.J. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One 2011, 6(12):e29662.
38. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 2006, 83(6 Suppl):1483S-1493S.
39. Cleland L.G., James M.J., Neumann M.A., D'Angelo M., Gibson R.A. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr 1992, 55(2):395-399.
40. National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106(25):3143.
41. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
42. Kadish A.H., Hall D.A. Anew method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem 1965, 11(9):869-875.
43. Allauzen S., Joly S., Granier C., et al. Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residues. Mol Immunol 1995, 32(1):27-36.
44. Diabetes Trial Unit. HOMA Calculator. Accessed February 1,2012. http://www.dtu.ox.ac.uk/homacalculator/index.php.
45. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
46. Hussein N., Ah-Sing E., Wilkinson P., Leach C., Griffin B.A., Millward D.J. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. JLipid Res 2005, 46(2):269-280.
47. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. JLipid Res 2001, 42(8):1257-1265.
48. D'Andrea S., Guillou H., Jan S., et al. The same rat delta 6-desaturase not only acts on 18- but also on 24-carbon fatty acids in very-long-chain polyunsaturated fatty acid biosynthesis. Biochem J 2002, 364(Pt 1):49-55.
49. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83(6 suppl):1467S-1476S.
50. Saito Y., Yokoyama M., Origasa H., et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008, 200(1):135-140.
51. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, 189(1):19-30.
52. Bays H.E., Ballantyne C.M., Kastelein J.J., Isaacsohn J.L., Braeckman R.A., Soni P.N. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am J Cardiol 2011, 108(5):682-690.
53. Harris W.S. n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 1997, 65(5 suppl):1645S-1654S.
54. Jacobson T.A. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 2008, 87(6):1981S-1990S.
55. Mori T.A., Woodman R.J. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006, 9(2):95-104.
56. US Food and Drug Adminisration. Agency response letter GRASnotice no. GRN 000283. 2009. Accessed October 29,2011. http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm185688.htm.
57. Miles E.A., Banerjee T., Calder P.C. Self-reported health problems in young male subjects supplementing their diet with oils rich in eicosapentaenoic, gamma-linolenic and stearidonic acids. Prostaglandins Leukot Essent Fatty Acids 2006, 75(1):57-60.
58. Whelan J., Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr 2006, 26:75-103.